CACO-2 permeability assay help determine the absorption rate, which is the compound's bioavailability, and helps predict the absorption during in vivo studies. Our ADME services team determines the absorption of the New Chemical Entity (NCE) by dosing it on Colon Carcinoma Cells (CACO-2).
Our CACO-2 assay is a monolayer membrane that can be tailored to your requirements and meet regulatory requirements. We can also help our clients understand unidirectional and bi-direction permeability.
| Assay | Analysis | Data turn around time |
| Caco-2 permeability | LC-MS/MS | 5 days* |
*21 days are required for Caco-2 cell cultures
Would you like to have a
Virtual Tour of ADME/DMPK Labs! Visit Now
Our CACO-2 Transwell Protocol and Capabilities Include:
- Permeability assessment: apical to basolateral transport
- Assess if the test compound is a substrate or inhibitor of efflux transporters
- Monitored transporters: P-gp and BCRP
- Deliverables: Papp, efflux ratio, percentage inhibition of transporters by the test compound
- Capacity: Permeability assessment: 200 compounds per month. Transporter assessment: 50 compounds per month
Aurigene Pharmaceutical Services is
one of the leading contract research organization (CRO)
provides the best contract research manufacturing
Virtual Tour
Contact Us
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.